Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) Assets Average (2021 - 2025)

Historic Assets Average for Coeptis Therapeutics Holdings (COEP) over the last 5 years, with Q3 2025 value amounting to $13.2 million.

  • Coeptis Therapeutics Holdings' Assets Average changed N/A to $13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year change of. This contributed to the annual value of $6.7 million for FY2024, which is 795.22% up from last year.
  • Latest data reveals that Coeptis Therapeutics Holdings reported Assets Average of $13.2 million as of Q3 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Assets Average peaked at $76.5 million during Q2 2021, and registered a low of $5.9 million during Q4 2023.
  • Moreover, its 5-year median value for Assets Average was $13.0 million (2025), whereas its average is $26.5 million.
  • As far as peak fluctuations go, Coeptis Therapeutics Holdings' Assets Average crashed by 8799.39% in 2023, and later surged by 6012.22% in 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Assets Average (Quarter) stood at $41.6 million in 2021, then tumbled by 50.42% to $20.6 million in 2022, then tumbled by 71.51% to $5.9 million in 2023, then soared by 52.14% to $8.9 million in 2024, then surged by 47.63% to $13.2 million in 2025.
  • Its Assets Average was $13.2 million in Q3 2025, compared to $12.8 million in Q2 2025 and $11.2 million in Q1 2025.